viernes, 8 de diciembre de 2023
Data-driven discovery of innate immunomodulators via machine learning-guided high throughput screening†
https://pubs.rsc.org/en/content/articlelanding/2023/SC/D3SC03613H Machine learning + high-throughput screening was used to find small molecules with big impacts on the innate immune system when used as vaccine adjuvants, reports a new article in Chemical Science. In the NIAID-funded study, researchers at the University of Chicago developed a screening pipeline aided by a novel artificial intelligence tool for the rapid discovery of immune modulators and built a library of small molecules that can tune innate immune pathways. The authors say this work could be used to rapidly reveal novel ways to improve vaccination and immune treatments.